Health In Tech (HIT) Cash & Equivalents (2023 - 2025)

Health In Tech's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $7.7 million for Q4 2025.

• On a quarterly basis, Cash & Equivalents fell 2.29% year-over-year to $7.7 million in Q4 2025; TTM through Dec 2025 was $7.7 million, a 2.29% decrease from a year earlier, with the FY2025 full-year figure at $7.7 million, down 2.29% from the prior year.
• Cash & Equivalents eased to $7.7 million in Q4 2025 per HIT's latest filing, from $8.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $8.1 million in Q2 2025 and bottomed at $2.4 million in Q4 2023.
• The 3-year median for Cash & Equivalents is $7.8 million (2024), against an average of $6.9 million.
• Across the five-year window, Cash & Equivalents soared 224.84% in 2024 and declined 2.29% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $2.4 million in 2023, then surged by 224.84% to $7.8 million in 2024, then dropped by 2.29% to $7.7 million in 2025.
• Per Business Quant, the three latest HIT Cash & Equivalents figures stand at $7.7 million (Q4 2025), $8.0 million (Q3 2025), and $8.1 million (Q2 2025).